: 25014756  [PubMed - in process]151. Int J Organ Transplant Med. 2014;5(2):83-6.Management of heparin-induced thrombocytopenia with fondaparinux in a patientwith left ventricular assist device.Velagic V(1), Samardzic J(2), Baricevic Z(1), Skoric B(2), Cikes M(2), GasparovicH(3), Biocina B(3), Milicic D(2).Author information: (1)Department for Cardiovascular Diseases, University Hospital Centre Zagreb,Croatia. (2)Department for Cardiovascular Diseases, University Hospital CentreZagreb, Croatia ; University of Zagreb School of Medicine, Zagreb, Croatia.(3)University of Zagreb School of Medicine, Zagreb, Croatia ; Department ofCardiac Surgery, University Hospital Centre Zagreb, Croatia.Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It is a relatively frequent complication among patients withmechanical circulatory support. Herein, we present a patient with severe heartfailure and sepsis who developed heparin-induced thrombocytopenia shortly afterimplantation of left ventricular assist device as a bridge to transplantation andwho was successfully treated with fondaparinux.PMCID: PMC4089335